Eli Lilly & Co. shares owned by Marietta Investment Partners
Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Marietta Investment Partners
from 13F filings
Historical chart of Marietta Investment Partners investment in Eli Lilly & Co.
Tip: Access up to 7 years of quarterly data
All positions including Eli Lilly & Co. held by Marietta Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eli Lilly & Co. by Marietta Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.6M | 4.7k | 763.00 |
| 2025-06-30 | $3.6M | 4.6k | 779.53 |
| 2025-03-31 | $3.9M | 4.8k | 825.91 |
| 2024-12-31 | $4.1M | 5.3k | 772.00 |
| 2024-09-30 | $7.0M | 7.9k | 885.94 |
| 2024-06-30 | $7.4M | 8.1k | 905.38 |
| 2024-03-31 | $3.7M | 4.7k | 777.96 |
| 2023-09-30 | $2.1M | 3.9k | 537.13 |
| 2023-06-30 | $1.8M | 3.9k | 468.98 |
| 2023-03-31 | $1.3M | 3.9k | 343.42 |
| 2022-12-31 | $1.4M | 3.9k | 365.84 |
| 2022-09-30 | $1.4M | 3.9k | 357.29 |
| 2022-06-30 | $1.3M | 3.9k | 324.30 |
| 2022-03-31 | $1.1M | 3.9k | 286.45 |
| 2021-12-31 | $1.1M | 3.9k | 276.21 |
| 2021-09-30 | $880k | 3.8k | 230.97 |
| 2021-06-30 | $874k | 3.8k | 229.40 |
| 2021-03-31 | $712k | 3.8k | 186.88 |
| 2020-12-31 | $810k | 4.8k | 168.75 |
| 2020-09-30 | $710k | 4.8k | 147.92 |
| 2020-06-30 | $788k | 4.8k | 164.17 |
| 2020-03-31 | $666k | 4.8k | 138.75 |
| 2019-12-31 | $686k | 5.2k | 131.39 |
| 2019-09-30 | $1.5M | 13k | 111.84 |
| 2019-06-30 | $1.7M | 16k | 110.79 |
| 2019-03-31 | $2.0M | 16k | 129.73 |
| 2018-12-31 | $1.8M | 16k | 115.73 |
| 2018-09-30 | $628k | 5.9k | 107.35 |
| 2016-09-30 | $332k | 4.1k | 80.29 |
| 2016-06-30 | $317k | 4.0k | 78.76 |
| 2016-03-31 | $266k | 3.7k | 71.89 |
| 2015-12-31 | $312k | 3.7k | 84.32 |
| 2015-09-30 | $298k | 3.7k | 80.54 |
| 2015-06-30 | $309k | 3.7k | 83.51 |
More positions owned by Marietta Investment Partners
View all positions for Marietta Investment Partners